Virological issues in the use of cell therapies.


The testing of cells and starting materials for biological medicinal products made from human sources has tended to focus on blood-borne viruses and those with a tropism for B lymphocytes, probably arising from the existing guidance on human monoclonal antibodies and experience with proteins fractionated from human blood. This may not be the best course… (More)


  • Presentations referencing similar topics